Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09JYF
|
||||
Former ID |
DIB011945
|
||||
Drug Name |
Epocarbazolin-A
|
||||
Synonyms |
Epocarbazolin-B
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Asthma [ICD10:J45] | Terminated | [1] | ||
Company |
Bristol-Myers Squibb Co
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C22H27NO4
|
||||
Canonical SMILES |
C1(OC1(CCC(C)C)C)c1c2[nH]c3c(c2cc(c1C)O)c(ccc3O)CO
|
||||
CAS Number |
CAS 146935-39-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Aspirin-triggered lipoxin biosynthesis | ||||
Resolvin D biosynthesis | |||||
Leukotriene biosynthesis | |||||
Lipoxin biosynthesis | |||||
Aspirin triggered resolvin D biosynthesis | |||||
Aspirin triggered resolvin E biosynthesis | |||||
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Toxoplasmosis | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Vitamin D Receptor Pathway | ||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | Epocarbazolins A and B, novel 5-lipoxygenase inhibitors. Taxonomy, fermentation, isolation, structures and biological activities. J Antibiot (Tokyo). 1993 Jan;46(1):25-33. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.